BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32981992)

  • 1. Sensitivity Analysis for Unmeasured Confounding in Meta-Analyses.
    Mathur MB; VanderWeele TJ
    J Am Stat Assoc; 2020; 115(529):163-172. PubMed ID: 32981992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of unmeasured within- and between-cluster confounding on the bias of effect estimatorsof a continuous exposure.
    Li Y; Lee Y; Port FK; Robinson BM
    Stat Methods Med Res; 2020 Aug; 29(8):2119-2139. PubMed ID: 31694489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the impact of unmeasured confounding for binary outcomes using confounding functions.
    Kasza J; Wolfe R; Schuster T
    Int J Epidemiol; 2017 Aug; 46(4):1303-1311. PubMed ID: 28338913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study.
    Fewell Z; Davey Smith G; Sterne JA
    Am J Epidemiol; 2007 Sep; 166(6):646-55. PubMed ID: 17615092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust Metrics and Sensitivity Analyses for Meta-analyses of Heterogeneous Effects.
    Mathur MB; VanderWeele TJ
    Epidemiology; 2020 May; 31(3):356-358. PubMed ID: 32141922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
    Zhang X; Stamey JD; Mathur MB
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies.
    Barrowman MA; Peek N; Lambie M; Martin GP; Sperrin M
    BMC Med Res Methodol; 2019 Jul; 19(1):166. PubMed ID: 31366331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An E-value analysis of potential unmeasured or residual confounding in systematic reviews of post-tuberculosis mortality, respiratory disease, and cardiovascular disease.
    Basham CA; Karim ME
    Ann Epidemiol; 2022 Apr; 68():24-31. PubMed ID: 34973421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SENSITIVITY ANALYSIS FOR UNMEASURED CONFOUNDING IN COARSE STRUCTURAL NESTED MEAN MODELS.
    Yang S; Lok JJ
    Stat Sin; 2018 Oct; 28(4):1703-1723. PubMed ID: 30853756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias?
    Masarwa R; Platt RW; Filion KB
    Paediatr Perinat Epidemiol; 2020 May; 34(3):309-317. PubMed ID: 31916282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity analysis for the effects of multiple unmeasured confounders.
    Groenwold RH; Sterne JA; Lawlor DA; Moons KG; Hoes AW; Tilling K
    Ann Epidemiol; 2016 Sep; 26(9):605-11. PubMed ID: 27576907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unifying instrumental variable and inverse probability weighting approaches for inference of causal treatment effect and unmeasured confounding in observational studies.
    Liu T; Hogan JW
    Stat Methods Med Res; 2021 Mar; 30(3):671-686. PubMed ID: 33213292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
    Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
    Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity Analysis Without Assumptions.
    Ding P; VanderWeele TJ
    Epidemiology; 2016 May; 27(3):368-77. PubMed ID: 26841057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing causal treatment effect estimation when using large observational datasets.
    John ER; Abrams KR; Brightling CE; Sheehan NA
    BMC Med Res Methodol; 2019 Nov; 19(1):207. PubMed ID: 31726969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Bias Due to Unmeasured Confounding in Oral Health Epidemiology.
    Mittinty MN
    Community Dent Health; 2020 Feb; 37(1):84-89. PubMed ID: 32031350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A FLEXIBLE SENSITIVITY ANALYSIS APPROACH FOR UNMEASURED CONFOUNDING WITH MULTIPLE TREATMENTS AND A BINARY OUTCOME WITH APPLICATION TO SEER-MEDICARE LUNG CANCER DATA.
    Hu L; Zou J; Gu C; Ji J; Lopez M; Kale M
    Ann Appl Stat; 2022 Jun; 16(2):1014-1037. PubMed ID: 36644682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.
    Brumback BA; Hernán MA; Haneuse SJ; Robins JM
    Stat Med; 2004 Mar; 23(5):749-67. PubMed ID: 14981673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods to Address Confounding and Other Biases in Meta-Analyses: Review and Recommendations.
    Mathur MB; VanderWeele TJ
    Annu Rev Public Health; 2022 Apr; 43():19-35. PubMed ID: 34535060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.